Concepedia
Statistics
Publications
13
Citations
584
H-Index
12
Active since
2008
Affiliations
Bristol-Myers Squibb (United States)(Current)
Memorial Sloan Kettering Cancer Center
Bristol-Myers Squibb (Belgium)
J. D. Wolchok is an author at Bristol-Myers Squibb (United States) specializing in medicine, immunology, and immunotherapy.
Top concepts
MedicineImmunologyImmunotherapyOncologyTumor ImmunityDermatologyCancer TherapyHealthClinical TrialsAutoimmune Disease
Publications per year
2008–2015
Evaluation of serum IL-17 levels during ipilimumab therapy: Correlation with colitis.
Margaret K. Callahan, Aili Yang, S Tandon et al. · Journal of Clinical Oncology · 2011 · 130 citations
Chronic Inflammatory Diseases, Clinical Symptoms, Serum Il-17 +19
Safety and antitumor activity of biweekly MDX-1106 (Anti-PD-1, BMS-936558/ONO-4538) in patients with advanced refractory malignancies.
Mario Sznol, John D. Powderly, David C. Smith et al. · Journal of Clinical Oncology · 2010 · 84 citations
Antitumor Activity, Immunology, Immunoediting +16
Poultry enteric inflammation model with dextran sodium sulfate mediated chemical induction and feed restriction in broilers
V.A. Kuttappan, L. Berghman, E.A. Vicuña et al. · Poultry Science · 2015 · 75 citations · Full text
Immunology, Gastroenterology, Education +21
Xenogeneic Murine Tyrosinase DNA Vaccine for Malignant Melanoma of the Digit of Dogs
Christina Manley, Nicole F. Leibman, J. D. Wolchok et al. · Journal of Veterinary Internal Medicine · 2010 · 74 citations · Full text
Association between immune-related adverse events (irAEs) and disease control or overall survival in patients (pts) with advanced melanoma treated with 10 mg/kg ipilimumab in three phase II clinical trials
Jose Lutzky, J. D. Wolchok, Omid Hamid et al. · Journal of Clinical Oncology · 2009 · 57 citations
Immunology, Immunoediting, Dermatology +19
1–5 of 13